{
    "references": [
        {
            "bibentry": "Jameel, E, Meena, P, Maqbool, M. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents. Eur J Med Chem 2017; 136: 36–51. PMID: 28478343",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2017.04.064",
            "pmid": "28478343",
            "xmlid": "CIT0001"
        },
        {
            "bibentry": "Borroni, E, Bohrmann, B, Grueninger, F, et al. Sembragiline: a novel, selective monoamine oxidase type B inhibitor for the treatment of Alzheimer's disease. J Pharmacol Exp Ther 2017; 362: 413–23. PMID: 28642233",
            "process_entry": "True",
            "doi": "10.1124/jpet.117.241653",
            "pmid": "28642233",
            "xmlid": "CIT0002"
        },
        {
            "bibentry": "Goedert, M, Spillantini, MG. A century of Alzheimer's disease. Science 2006; 314: 777–81. PMID: 17082447",
            "process_entry": "True",
            "doi": "10.1126/science.1132814",
            "pmid": "17082447",
            "xmlid": "CIT0003"
        },
        {
            "bibentry": "Finder, VH. Alzheimer's disease: a general introduction and pathomechanism. J Alzheimers Dis 2010; 22: 5–19. PMID: 20858960",
            "process_entry": "True",
            "doi": "10.3233/jad-2010-100975",
            "pmid": "20858960",
            "xmlid": "CIT0004"
        },
        {
            "bibentry": "Savelieff, MG, Lee, S, Liu, Y, Lim, MH. Untangling amyloid-β, tau, and metals in Alzheimer's disease. ACS Chem Biol 2013; 8: 856–65. PMID: 23506614",
            "process_entry": "True",
            "doi": "10.1021/cb400080f",
            "pmid": "23506614",
            "xmlid": "CIT0005"
        },
        {
            "bibentry": "Bush, AI. Drug development based on the metals hypothesis of Alzheimer's disease. J Alzheimers Dis 2008; 15: 223–40. PMID: 18953111",
            "process_entry": "True",
            "pmid": "18953111",
            "xmlid": "CIT0006"
        },
        {
            "bibentry": "Opazo, C, Huang, X, Cherny, RA, et al. Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). J Biol Chem 2002; 277: 40302–8. PMID: 12192006",
            "process_entry": "True",
            "doi": "10.1074/jbc.m206428200",
            "pmid": "12192006",
            "xmlid": "CIT0007"
        },
        {
            "bibentry": "Wilkinson, D, Wirth, Y, Goebel, C. Memantine in patients with moderate to severe Alzheimer’s disease: meta-analyses using realistic definitions of response. Dement Geriatr Cogn Disord 2014; 37: 71–85. PMID: 24107324",
            "process_entry": "True",
            "doi": "10.1159/000353801",
            "pmid": "24107324",
            "xmlid": "CIT0008"
        },
        {
            "bibentry": "Bond, M, Rogers, G, Peters, J, et al. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model. Health Technol Assess 2012; 16: 1–470. [ DOI: 10.3310/hta16210]",
            "process_entry": "True",
            "doi": "10.3310/hta16210]",
            "xmlid": "CIT0009"
        },
        {
            "bibentry": "Perez, D, Martinez, A, Gil, C, Campillo, N. From bitopic inhibitors to multitarget drugs for the future treatment of Alzheimer’s disease. Curr Med Chem 2015; 22: 3789–806. PMID: 26264921",
            "process_entry": "True",
            "doi": "10.2174/0929867322666150812145825",
            "pmid": "26264921",
            "xmlid": "CIT0010"
        },
        {
            "bibentry": "Agis-Torres, A, Sollhuber, M, Fernandez, M, Sanchez-Montero, JM. Multi-target-directed ligands and other therapeutic strategies in the search of a real solution for Alzheimer’s disease. Curr Neuropharmacol 2014; 12: 2–36. PMID: 24533013",
            "process_entry": "True",
            "doi": "10.2174/1570159X113116660047",
            "pmid": "24533013",
            "pmcid": "PMC3915347",
            "xmlid": "CIT0011"
        },
        {
            "bibentry": "Cavalli, A, Bolognesi, ML, Minarini, A, et al. Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem 2008; 51: 347–72. PMID: 18181565",
            "process_entry": "True",
            "doi": "10.1021/jm7009364",
            "pmid": "18181565",
            "xmlid": "CIT0012"
        },
        {
            "bibentry": "León, R, Garcia, AG, Marco-Contelles, J. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease. Med Res Rev 2013; 33: 139–89. PMID: 21793014",
            "process_entry": "True",
            "doi": "10.1002/med.20248",
            "pmid": "21793014",
            "xmlid": "CIT0013"
        },
        {
            "bibentry": "Rosini, M, Simoni, E, Caporaso, R, Minarini, A. Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics. Future Med Chem 2016; 8: 697–711. PMID: 27079260",
            "process_entry": "True",
            "doi": "10.4155/fmc-2016-0003",
            "pmid": "27079260",
            "xmlid": "CIT0014"
        },
        {
            "bibentry": "Ismaili, L, Refouvelet, B, Benchekroun, M, et al. Multitarget compounds bearing tacrine-and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease. Prog Neurobiol 2017; 151: 4–34. PMID: 26797191",
            "process_entry": "True",
            "doi": "10.1016/j.pneurobio.2015.12.003",
            "pmid": "26797191",
            "xmlid": "CIT0015"
        },
        {
            "bibentry": "Benchekroun, M, Ismaili, L, Pudlo, M, et al. Donepezil-ferulic acid hybrids as anti-Alzheimer drugs. Future Med Chem 2015; 7: 15–21. PMID: 25582330",
            "process_entry": "True",
            "doi": "10.4155/fmc.14.148",
            "pmid": "25582330",
            "xmlid": "CIT0016"
        },
        {
            "bibentry": "Benchekroun, M, Romero, A, Egea, J, et al. The antioxidant additive approach for Alzheimer’s disease therapy: new ferulic (lipoic) acid plus melatonin modified tacrines as cholinesterases inhibitors, direct antioxidants, and nuclear factor (erythroid-derived 2)-like 2 activators. J Med Chem 2016; 59: 9967–73. PMID: 27736061",
            "process_entry": "True",
            "doi": "10.1021/acs.jmedchem.6b01178",
            "pmid": "27736061",
            "xmlid": "CIT0017"
        },
        {
            "bibentry": "Dgachi, Y, Sokolov, O, Luzet, V, et al. Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer’s disease therapy. Eur J Med Chem 2017; 126: 576–89. PMID: 27918993",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2016.11.050",
            "pmid": "27918993",
            "xmlid": "CIT0018"
        },
        {
            "bibentry": "Dgachi, Y, Ismaili, L, Knez, D, et al. Synthesis and biological assessment of racemic benzochromenopyrimidinimines as antioxidant, cholinesterase, and Aβ1 − 42 aggregation inhibitors for Alzheimer’s disease therapy. ChemMedChem 2016; 11: 1318–27. PMID: 26804623",
            "process_entry": "True",
            "doi": "10.1002/cmdc.201500539",
            "pmid": "26804623",
            "xmlid": "CIT0019"
        },
        {
            "bibentry": "Watkins, PB, Zimmerman, HJ, Knapp, MJ, et al. HEpatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA 1994; 271: 992–8. PMID: 8139084",
            "process_entry": "True",
            "doi": "10.1001/jama.1994.03510370044030",
            "pmid": "8139084",
            "xmlid": "CIT0020"
        },
        {
            "bibentry": "Boulebd, H, Ismaili, L, Martin, H, et al. New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease. Future Med Chem 2017; 9: 723–9. PMID: 28485637",
            "process_entry": "True",
            "doi": "10.4155/fmc-2017-0019",
            "pmid": "28485637",
            "xmlid": "CIT0021"
        },
        {
            "bibentry": "Gomes, AJ, Lunardi, CN, Gonzalez, S, Tedesco, AC. The antioxidant action of polypodium leucotomos extract and kojic acid: reactions with reactive oxygen species. Braz J Med Biol Res 2001; 34: 1487–94. PMID: 11668361",
            "process_entry": "True",
            "doi": "10.1590/s0100-879x2001001100018",
            "pmid": "11668361",
            "xmlid": "CIT0022"
        },
        {
            "bibentry": "Emami, S, Hosseinimehr, SJ, Taghdisi, SM, Akhlaghpoor, S. Kojic acid and its manganese and zinc complexes as potential radioprotective agents. Bioorg Med Chem Lett 2007; 17: 45–8. PMID: 17049858",
            "process_entry": "True",
            "doi": "10.1016/j.bmcl.2006.09.097",
            "pmid": "17049858",
            "xmlid": "CIT0023"
        },
        {
            "bibentry": "Kataev, EA, Reddy, MR, Reddy, GN, et al. Supramolecular catalysis by β-cyclodextrin for the synthesis of kojic acid derivatives in water. New J Chem 2016; 40: 1693–7.",
            "process_entry": "True",
            "xmlid": "CIT0024"
        },
        {
            "bibentry": "Bartolini, M, Pistolozzi, M, Andrisano, V, et al. Chemical and pharmacological studies on enantiomerically pure p-methoxytacripyrines, promising multi-target-directed ligands for the treatment of Alzheimer’s disease. ChemMedChem 2011; 6: 1990–7. PMID: 21990269",
            "process_entry": "True",
            "doi": "10.1002/cmdc.201100239",
            "pmid": "21990269",
            "xmlid": "CIT0025"
        },
        {
            "bibentry": "Denizot, F, Lang, R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986; 89: 271–7. PMID: 3486233",
            "process_entry": "True",
            "doi": "10.1016/0022-1759(86)90368-6",
            "pmid": "3486233",
            "xmlid": "CIT0026"
        },
        {
            "bibentry": "Decker, M. Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase. J Med Chem 2006; 49: 5411–3. PMID: 16942014",
            "process_entry": "True",
            "doi": "10.1021/jm060682m",
            "pmid": "16942014",
            "xmlid": "CIT0027"
        },
        {
            "bibentry": "Ellman, GL, Courtney, KD, Andres, V, Featherstone, RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88–95. PMID: 13726518",
            "process_entry": "True",
            "doi": "10.1016/0006-2952(61)90145-9",
            "pmid": "13726518",
            "xmlid": "CIT0028"
        },
        {
            "bibentry": "Benchekroun, M, Bartolini, M, Egea, J, et al. Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids. ChemMedChem 2015; 10: 523–39. PMID: 25537267",
            "process_entry": "True",
            "doi": "10.1002/cmdc.201402409",
            "pmid": "25537267",
            "xmlid": "CIT0029"
        },
        {
            "bibentry": "Dávalos, A, Gómez-Cordovés, C, Bartolomé, B. Extending applicability of the oxygen radical absorbance capacity (ORAC-fluorescein) assay. J Agric Food Chem 2004; 52: 48–54. PMID: 14709012",
            "process_entry": "True",
            "doi": "10.1021/jf0305231",
            "pmid": "14709012",
            "xmlid": "CIT0030"
        },
        {
            "bibentry": "Dgachi, Y, Bautista-Aguilera, OM, Benchekroun, M, et al. Synthesis and biological evaluation of benzochromenopyrimidinones as cholinesterase inhibitors and potent antioxidant, non-hepatotoxic agents for Alzheimer’s disease. Molecules 2016; 21: 634.",
            "process_entry": "True",
            "xmlid": "CIT0031"
        },
        {
            "bibentry": "Trott, O, Olson, AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010; 31: 455–61. PMID: 19499576",
            "process_entry": "True",
            "doi": "10.1002/jcc.21334",
            "pmid": "19499576",
            "pmcid": "PMC3041641",
            "xmlid": "CIT0032"
        },
        {
            "bibentry": "Brooks, BR, Bruccoleri, RE, Olafson, BD, et al. CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 1983; 4: 187–217.",
            "process_entry": "True",
            "xmlid": "CIT0033"
        },
        {
            "bibentry": "Piao, M-Z, Imafuku, K. Convenient synthesis of amino-substituted pyranopyranones. Tetrahedron Lett 1997; 38: 5301–2.",
            "process_entry": "True",
            "xmlid": "CIT0034"
        },
        {
            "bibentry": "Marco-Contelles, J, Pérez-Mayoral, E, Samadi, A, et al. Recent advances in the Friedländer reaction. Chem Rev 2009; 109: 2652–71. PMID: 19361199",
            "process_entry": "True",
            "doi": "10.1021/cr800482c",
            "pmid": "19361199",
            "xmlid": "CIT0035"
        },
        {
            "bibentry": "Ou, B, Hampsch-Woodill, M, Prior, RL. Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. J Agric Food Chem 2001; 49: 4619–26. PMID: 11599998",
            "process_entry": "True",
            "doi": "10.1021/jf010586o",
            "pmid": "11599998",
            "xmlid": "CIT0036"
        },
        {
            "bibentry": "Fang, L, Kraus, B, Lehmann, J, et al. Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates. Bioorg Med Chem Lett 2008; 18: 2905–9. PMID: 18406135",
            "process_entry": "True",
            "doi": "10.1016/j.bmcl.2008.03.073",
            "pmid": "18406135",
            "xmlid": "CIT0037"
        },
        {
            "bibentry": "Shi, C, Zhao, L, Zhu, B, et al. Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against beta-amyloid peptide-induced toxicity in SH-SY5Y cells. Chem Biol Interact 2009; 181: 115–23. PMID: 19464278",
            "process_entry": "True",
            "doi": "10.1016/j.cbi.2009.05.010",
            "pmid": "19464278",
            "xmlid": "CIT0038"
        },
        {
            "bibentry": "González-Muñoz, GC, Arce, MP, López, B, et al. N-Acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease. Eur J Med Chem 2011; 46: 2224–35. PMID: 21420206",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2011.03.003",
            "pmid": "21420206",
            "xmlid": "CIT0039"
        },
        {
            "bibentry": "Martins, C, Carreiras, MC, León, R, et al. Synthesis and biological assessment of diversely substituted furo[2,3-b]quinolin-4-amine and pyrrolo[2,3-b]quinolin-4-amine derivatives, as novel tacrine analogues. Eur J Med Chem 2011; 46: 6119–30. PMID: 22000936",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2011.09.038",
            "pmid": "22000936",
            "xmlid": "CIT0040"
        }
    ],
    "localid": "MED-30482062",
    "doi": "10.1080/14756366.2018.1538136",
    "pmid": "10.1080/14756366.2018.1538136",
    "pmcid": "30482062",
    "curator": "BEE EuropeanPubMedCentralProcessor",
    "source_provider": "Europe PubMed Central",
    "source": "https://www.ebi.ac.uk/europepmc/webservices/rest/30482062/fullTextXML",
    "reference_pointers": [
        [
            {
                "n_rp": 0,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),109,94)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 1,
                "xref_id": "CIT0003",
                "rp_string": "3",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),205,155)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 2,
                "xref_id": "CIT0005",
                "rp_string": "5",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),362,344)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "The World Health Organization claims that 46 million people worldwide suffer from Alzheimer’s disease (AD). It is likely that this number may significantly rise as the life expectancy increases1,2. AD is a multifactorial neurodegenerative disorder, inducing a progressive memory loss, decline in language skills, and other cognitive impairments3,4. Although the aetiology of the disease is still not fully understood5, low levels of acetylcholine (ACh), the aggregation of amyloid-beta peptide (Aβ), hyperphosphorylation of tau protein, oxidative stress, and accumulation of biometals (Cu, Fe, Zn) are thought to play key roles in the pathophysiology, progress and development of AD6,7. AD patients are currently treated either with the N-methyl-D-aspartate receptor antagonist, memantine8, or donepezil, rivastigmine, and galantamine9, three acetylcholinesterase inhibitors (AChEIs), but with limited therapeutic success. Consequently, there is an urgent need for new and more efficient drugs for AD therapy.",
                "pl_xpath": "/article/body/sec[1]/p[1]"
            },
            {
                "n_rp": 3,
                "xref_id": "CIT0006",
                "rp_string": "6",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),362,344)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "The World Health Organization claims that 46 million people worldwide suffer from Alzheimer’s disease (AD). It is likely that this number may significantly rise as the life expectancy increases1,2. AD is a multifactorial neurodegenerative disorder, inducing a progressive memory loss, decline in language skills, and other cognitive impairments3,4. Although the aetiology of the disease is still not fully understood5, low levels of acetylcholine (ACh), the aggregation of amyloid-beta peptide (Aβ), hyperphosphorylation of tau protein, oxidative stress, and accumulation of biometals (Cu, Fe, Zn) are thought to play key roles in the pathophysiology, progress and development of AD6,7. AD patients are currently treated either with the N-methyl-D-aspartate receptor antagonist, memantine8, or donepezil, rivastigmine, and galantamine9, three acetylcholinesterase inhibitors (AChEIs), but with limited therapeutic success. Consequently, there is an urgent need for new and more efficient drugs for AD therapy.",
                "pl_xpath": "/article/body/sec[1]/p[1]"
            },
            {
                "n_rp": 4,
                "xref_id": "CIT0007",
                "rp_string": "7",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),362,344)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "The World Health Organization claims that 46 million people worldwide suffer from Alzheimer’s disease (AD). It is likely that this number may significantly rise as the life expectancy increases1,2. AD is a multifactorial neurodegenerative disorder, inducing a progressive memory loss, decline in language skills, and other cognitive impairments3,4. Although the aetiology of the disease is still not fully understood5, low levels of acetylcholine (ACh), the aggregation of amyloid-beta peptide (Aβ), hyperphosphorylation of tau protein, oxidative stress, and accumulation of biometals (Cu, Fe, Zn) are thought to play key roles in the pathophysiology, progress and development of AD6,7. AD patients are currently treated either with the N-methyl-D-aspartate receptor antagonist, memantine8, or donepezil, rivastigmine, and galantamine9, three acetylcholinesterase inhibitors (AChEIs), but with limited therapeutic success. Consequently, there is an urgent need for new and more efficient drugs for AD therapy.",
                "pl_xpath": "/article/body/sec[1]/p[1]"
            }
        ],
        [
            {
                "n_rp": 5,
                "xref_id": "CIT0008",
                "rp_string": "8",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),708,238)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 6,
                "xref_id": "CIT0009",
                "rp_string": "9",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),708,238)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 13,
                "xref_id": "CIT0010",
                "rp_string": "10–15",
                "pl_string": "10–15",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,302)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 8,
                "xref_id": "",
                "pl_string": "10–15",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,302)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 9,
                "xref_id": "",
                "pl_string": "10–15",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,302)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 10,
                "xref_id": "",
                "pl_string": "10–15",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,302)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 11,
                "xref_id": "",
                "pl_string": "10–15",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,302)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 12,
                "xref_id": "",
                "pl_string": "10–15",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,302)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 13,
                "xref_id": "CIT0010",
                "rp_string": "10–15",
                "pl_string": "10–15",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,302)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 18,
                "xref_id": "CIT0016",
                "rp_string": "16–19",
                "pl_string": "16–19",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),305,177)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 15,
                "xref_id": "",
                "pl_string": "16–19",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),305,177)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 16,
                "xref_id": "",
                "pl_string": "16–19",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),305,177)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 17,
                "xref_id": "",
                "pl_string": "16–19",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),305,177)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 18,
                "xref_id": "CIT0016",
                "rp_string": "16–19",
                "pl_string": "16–19",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),305,177)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 19,
                "xref_id": "CIT0020",
                "rp_string": "20",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),211,143)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 20,
                "xref_id": "CIT0013",
                "rp_string": "13",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),356,115)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 21,
                "xref_id": "CIT0021",
                "rp_string": "21",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),473,744)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 22,
                "xref_id": "CIT0022",
                "rp_string": "22",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1334,89)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 23,
                "xref_id": "CIT0024",
                "rp_string": "24",
                "rp_xpath": "/article/body/sec[2]/sec[1]/sec/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/sec/p),1,235)",
                "containers_title": [
                    "Methods",
                    "Chemistry",
                    "Amino-2-(hydroxymethyl)-12–(3-methoxyphenyl)-7,9,10,12-tetra hydropyrano[2',3':5,6] pyrano[2,3-b]quinolin-4(8H)-one (2d)"
                ]
            }
        ],
        [
            {
                "n_rp": 24,
                "xref_id": "CIT0013",
                "rp_string": "13",
                "rp_xpath": "/article/body/sec[2]/sec[1]/sec/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/sec/p),420,816)",
                "containers_title": [
                    "Methods",
                    "Chemistry",
                    "Amino-2-(hydroxymethyl)-12–(3-methoxyphenyl)-7,9,10,12-tetra hydropyrano[2',3':5,6] pyrano[2,3-b]quinolin-4(8H)-one (2d)"
                ]
            }
        ],
        [
            {
                "n_rp": 25,
                "xref_id": "CIT0017",
                "rp_string": "17",
                "rp_xpath": "/article/body/sec[2]/sec[2]/sec[1]/title/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[1]/title),1,68)",
                "containers_title": [
                    "Methods",
                    "Biological evaluation",
                    "In vitro cytotoxicity of KojoTacrines in HepG2 cells\n17\n\n,\n\n18\n\n,\n\n25"
                ],
                "pl_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[1]/title),52,11)",
                "pl_string": "s\n17\n\n,\n\n18"
            },
            {
                "n_rp": 26,
                "xref_id": "CIT0018",
                "rp_string": "18",
                "rp_xpath": "/article/body/sec[2]/sec[2]/sec[1]/title/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[1]/title),1,68)",
                "containers_title": [
                    "Methods",
                    "Biological evaluation",
                    "In vitro cytotoxicity of KojoTacrines in HepG2 cells\n17\n\n,\n\n18\n\n,\n\n25"
                ],
                "pl_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[1]/title),52,11)",
                "pl_string": "s\n17\n\n,\n\n18"
            }
        ],
        [
            {
                "n_rp": 27,
                "xref_id": "CIT0025",
                "rp_string": "25",
                "rp_xpath": "/article/body/sec[2]/sec[2]/sec[1]/title/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[1]/title),1,69)",
                "containers_title": [
                    "Methods",
                    "Biological evaluation",
                    "In vitro cytotoxicity of KojoTacrines in HepG2 cells\n17\n\n,\n\n18\n\n,\n\n25"
                ]
            }
        ],
        [
            {
                "n_rp": 28,
                "xref_id": "CIT0026",
                "rp_string": "26",
                "rp_xpath": "/article/body/sec[2]/sec[2]/sec[1]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[1]/p),265,133)",
                "containers_title": [
                    "Methods",
                    "Biological evaluation",
                    "In vitro cytotoxicity of KojoTacrines in HepG2 cells\n17\n\n,\n\n18\n\n,\n\n25"
                ]
            }
        ],
        [
            {
                "n_rp": 29,
                "xref_id": "CIT0017",
                "rp_string": "17",
                "rp_xpath": "/article/body/sec[2]/sec[2]/sec[2]/title/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[2]/title),1,77)",
                "containers_title": [
                    "Methods",
                    "Biological evaluation",
                    "Inhibition of EeAChE and eqBuChE of compounds KTs 2a–d, 2f–h, and 2l\n17\n\n,\n\n27"
                ]
            }
        ],
        [
            {
                "n_rp": 30,
                "xref_id": "CIT0027",
                "rp_string": "27",
                "rp_xpath": "/article/body/sec[2]/sec[2]/sec[2]/title/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[2]/title),1,78)",
                "containers_title": [
                    "Methods",
                    "Biological evaluation",
                    "Inhibition of EeAChE and eqBuChE of compounds KTs 2a–d, 2f–h, and 2l\n17\n\n,\n\n27"
                ]
            }
        ],
        [
            {
                "n_rp": 31,
                "xref_id": "CIT0028",
                "rp_string": "28",
                "rp_xpath": "/article/body/sec[2]/sec[2]/sec[2]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[2]/p),1,78)",
                "containers_title": [
                    "Methods",
                    "Biological evaluation",
                    "Inhibition of EeAChE and eqBuChE of compounds KTs 2a–d, 2f–h, and 2l\n17\n\n,\n\n27"
                ]
            }
        ],
        [
            {
                "n_rp": 32,
                "xref_id": "CIT0017",
                "rp_string": "17",
                "rp_xpath": "/article/body/sec[2]/sec[2]/sec[3]/title/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[3]/title),1,44)",
                "containers_title": [
                    "Methods",
                    "Biological evaluation",
                    "Inhibition of human cholinesterases\n17\n\n,\n\n27"
                ]
            }
        ],
        [
            {
                "n_rp": 33,
                "xref_id": "CIT0027",
                "rp_string": "27",
                "rp_xpath": "/article/body/sec[2]/sec[2]/sec[3]/title/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[3]/title),1,45)",
                "containers_title": [
                    "Methods",
                    "Biological evaluation",
                    "Inhibition of human cholinesterases\n17\n\n,\n\n27"
                ]
            }
        ],
        [
            {
                "n_rp": 34,
                "xref_id": "CIT0028",
                "rp_string": "28",
                "rp_xpath": "/article/body/sec[2]/sec[2]/sec[3]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[3]/p),1,181)",
                "containers_title": [
                    "Methods",
                    "Biological evaluation",
                    "Inhibition of human cholinesterases\n17\n\n,\n\n27"
                ]
            }
        ],
        [
            {
                "n_rp": 35,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[2]/sec[2]/sec[4]/title/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[4]/title),1,24)",
                "containers_title": [
                    "Methods",
                    "Biological evaluation",
                    "Neuroprotection assay\n29"
                ]
            }
        ],
        [
            {
                "n_rp": 36,
                "xref_id": "CIT0030",
                "rp_string": "30",
                "rp_xpath": "/article/body/sec[2]/sec[2]/sec[6]/title/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[6]/title),1,49)",
                "containers_title": [
                    "Methods",
                    "Biological evaluation",
                    "Oxygen radical absorbance capacity assay\n30\n\n,\n\n31"
                ]
            }
        ],
        [
            {
                "n_rp": 37,
                "xref_id": "CIT0031",
                "rp_string": "31",
                "rp_xpath": "/article/body/sec[2]/sec[2]/sec[6]/title/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[6]/title),1,50)",
                "containers_title": [
                    "Methods",
                    "Biological evaluation",
                    "Oxygen radical absorbance capacity assay\n30\n\n,\n\n31"
                ]
            }
        ],
        [
            {
                "n_rp": 38,
                "xref_id": "CIT0030",
                "rp_string": "30",
                "rp_xpath": "/article/body/sec[2]/sec[2]/sec[6]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec[6]/p),1,168)",
                "containers_title": [
                    "Methods",
                    "Biological evaluation",
                    "Oxygen radical absorbance capacity assay\n30\n\n,\n\n31"
                ]
            }
        ],
        [
            {
                "n_rp": 39,
                "xref_id": "CIT0032",
                "rp_string": "32",
                "rp_xpath": "/article/body/sec[2]/sec[3]/sec/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/sec/p),1,64)",
                "containers_title": [
                    "Methods",
                    "Molecular modelling",
                    "Molecular modelling of compound KT2d"
                ]
            }
        ],
        [
            {
                "n_rp": 40,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[2]/sec[3]/sec/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/sec/p),212,224)",
                "containers_title": [
                    "Methods",
                    "Molecular modelling",
                    "Molecular modelling of compound KT2d"
                ]
            }
        ],
        [
            {
                "n_rp": 41,
                "xref_id": "CIT0025",
                "rp_string": "25",
                "rp_xpath": "/article/body/sec[2]/sec[3]/sec/p/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/sec/p),1743,69)",
                "containers_title": [
                    "Methods",
                    "Molecular modelling",
                    "Molecular modelling of compound KT2d"
                ]
            }
        ],
        [
            {
                "n_rp": 42,
                "xref_id": "CIT0034",
                "rp_string": "34",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),231,279)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ]
            }
        ],
        [
            {
                "n_rp": 43,
                "xref_id": "CIT0035",
                "rp_string": "35",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),512,168)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ],
                "pl_string": "The synthesis of racemic KTs 11-amino-2-(hydroxymethyl)-12-aryl-7,9,10,12-tetrahydropyrano[2',3':5,6]pyrano[2,3-b]quinolin-4(8H)-ones (2a–l) was carried out in two steps by using easily available precursors, as shown in Scheme 1. Thus, KA was reacted with selected arylidenemalonitriles, in the presence of catalytic amounts of triethylamine, in ethanol, at 80 °C, for 5 min, to give the known 2-amino-6-(hydroxymethyl)-8-oxo-4-phenyl-4,8-dihydropyrano[3,2-b]pyran-3-carbonitriles 1a–l in very good yields34. Next, Friedländer-type reaction35 of compounds 1a–l with cyclohexanone, under the usual experimental conditions35, afforded the expected racemic KTs 2a–l (Scheme 1).",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]"
            },
            {
                "n_rp": 44,
                "xref_id": "CIT0035",
                "rp_string": "35",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),512,168)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ],
                "pl_string": "The synthesis of racemic KTs 11-amino-2-(hydroxymethyl)-12-aryl-7,9,10,12-tetrahydropyrano[2',3':5,6]pyrano[2,3-b]quinolin-4(8H)-ones (2a–l) was carried out in two steps by using easily available precursors, as shown in Scheme 1. Thus, KA was reacted with selected arylidenemalonitriles, in the presence of catalytic amounts of triethylamine, in ethanol, at 80 °C, for 5 min, to give the known 2-amino-6-(hydroxymethyl)-8-oxo-4-phenyl-4,8-dihydropyrano[3,2-b]pyran-3-carbonitriles 1a–l in very good yields34. Next, Friedländer-type reaction35 of compounds 1a–l with cyclohexanone, under the usual experimental conditions35, afforded the expected racemic KTs 2a–l (Scheme 1).",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]"
            }
        ],
        [
            {
                "n_rp": 45,
                "xref_id": "CIT0026",
                "rp_string": "26",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[1]/p[1]),99,208)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "In vitro cytotoxicity of KTs 2a–l in HepG2 cells"
                ]
            }
        ],
        [
            {
                "n_rp": 46,
                "xref_id": "CIT0028",
                "rp_string": "28",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[2]/p[1]/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[2]/p[1]),1,220)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Evaluation of AChE and BuChE inhibition of KTs 2a–d, 2f–h, and 2l"
                ]
            }
        ],
        [
            {
                "n_rp": 47,
                "xref_id": "CIT0030",
                "rp_string": "30",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[3]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[3]/p),1,224)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Evaluation of antioxidant power of KTs 2a–d, 2f–h, and 2l"
                ]
            }
        ],
        [
            {
                "n_rp": 48,
                "xref_id": "CIT0038",
                "rp_string": "38",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[4]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[4]/p[1]),1,433)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Neuroprotective capacity of KojoTacrines 2b–d and 2f"
                ]
            }
        ],
        [
            {
                "n_rp": 49,
                "xref_id": "CIT0039",
                "rp_string": "39",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[4]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[4]/p[1]),1,433)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Neuroprotective capacity of KojoTacrines 2b–d and 2f"
                ]
            }
        ],
        [
            {
                "n_rp": 50,
                "xref_id": "CIT0032",
                "rp_string": "32",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[4]/p[2]/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[4]/p[2]),87,221)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Neuroprotective capacity of KojoTacrines 2b–d and 2f"
                ]
            }
        ],
        [
            {
                "n_rp": 51,
                "xref_id": "CIT0025",
                "rp_string": "25",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[5]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[5]/p[1]),732,146)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "Molecular modelling of compound KT2d"
                ]
            }
        ]
    ]
}